TIMP-1 is a key factor of fibrogenic response to bleomycin in mouse lung

International Journal of Immunopathology and Pharmacology

Volumn 19, Issue 3, 2006, Pages 471-487

  Manoury, B ^a   Caulet Maugendre, S ^a   Guenon I ^a   Lagente, Vincent ^a   Boichot, E ^a  

^a UNIVERSITÉ DE RENNES 1   (France)

Author keywords

Bleomycin; Collagen; Matrix metalloproteinases; Pulmonary fibrosis; TIMP

Indexed keywords

BLEOMYCIN; GELATINASE A; GELATINASE B; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENE LOCATION; GENE SEQUENCE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LUNG FIBROSIS; LUNG LAVAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION;

EID: 33750058294     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200601900303     Document Type: Article

References (50)

1. Katzenstein A.L. and J.L. Myers. 1998. Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am. J. Respir. Crit. Care Med. 157:1301.
2. Crouch E. 1990. Pathobiology of pulmonary fibrosis. Am. J. Physiol. 259:159.
3. Crystal R.G., P.B. Bitterman, S.I. Rennard, A.J. Hance and B.A. Keogh. 1984. Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract (first of two parts). N. Engl. J. Med. 310:154.
4. Crystal R.G., P.B. Bitterman, B. Mossman, M.I. Schwarz, D. Sheppard, L. Almasy, H.A. Chapman, S.L. Friedman, T.E. King, L.A. Leinwand, L. Liotta, G.R. Martin, D.A. Schwartz, G.S. Schultz, C.R. Wagner and R.A. Musson. 2002. Future research directions in idiopathic pulmonary fibrosis: summary of a National Heart, Lung, and Blood Institute working group. Am. J. Respir. Crit. Care Med. 166:236.
5. Selman M., T.E. King and A. Pardo. 2001. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann. Intern. Med. 134:136.
6. Ward P.A. and G.W. Hunninghake. 1998. Lung inflammation and fibrosis. Am. J. Respir. Crit. Care Med. 157:123.
7. Khalil N. and R. O'Connor. 2004. Idiopathic pulmonary fibrosis: current understanding of the pathogenesis and the status of treatment. CMAJ. 171:153.
8. Richeldi L., H.R. Davies, G. Ferrara and F. Franco. 2003. Corticosteroids for idiopathic pulmonary fibrosis. Cochrane Database Syst. Rev. 3:3134.
9. Ortiz L.A., J. Lasky, R.F. Hamilton, A. Holian, G.W. Hoyle, W. Banks, J.J. Peschon, A.R. Brody, G. Lungarella and M. Friedman. 1998. Expression of TNF and the necessity of TNF receptors in bleomycin-induced lung injury in mice. Exp. Lung Res. 24:721.
10. Piguet P.F. and C. Vesin. 1994. Treatment by human recombinant soluble TNF receptor of pulmonary fibrosis induced by bleomycin or silica in mice. Eur. Respir. J. 7:515.
11. Baecher-Allan C.M. and R.K. Barth. 1993. PCR analysis of cytokine induction profiles associated with mouse strain variation in susceptibility to pulmonary fibrosis. Reg. Immunol. 5:207.
12. Gauldie J., M. Kolb and P.J. Sime. 2002. A new direction in the pathogenesis of idiopathic pulmonary fibrosis? Respir. Res. 3:1.
13. Selman M. and A. Pardo. 2002. Idiopathic pulmonary fibrosis: an epithelial/fibroblastic crosstalk disorder. Respir. Res. 3:3.
14. Corbel M., C. Belleguic, E. Boichot and V. Lagente. 2002. Involvement of gelatinases (MMP-2 and MMP-9) in the development of airway inflammation and pulmonary fibrosis. Cell Biol. Toxicol. 18:51.
15. Parks W.C. and S.D. Shapiro. 2001. Matrix metalloproteinases in lung biology. Respir. Res. 2:10.
16. Visse R. and H. Nagase. 2003. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ. Res. 92:827.
17. Corbel M., S. Caulet-Maugendre, N. Germain, S. Molet, V. Lagente and E. Boichot. 2001. Inhibition of bleomycin-induced pulmonary fibrosis in mice by the matrix metalloproteinase inhibitor batimastat. J. Pathol. 193:538.
18. Swiderski R.E., J.E. Dencoff, C.S. Floerchinger, S.D. Shapiro and G.W. Hunninghake. 1998. Differential expression of extracellular matrix remodeling genes in a murine model of bleomycin-induced pulmonary fibrosis. Am. J. Pathol. 152:821.
19. Selman M., V. Ruiz, S. Cabrera, L. Segura, R. Ramirez, R. Barrios and A. Pardo. 2000. TIMP-1, -2, -3, and -4 in idiopathic pulmonary fibrosis. A prevailing nondegradative lung microenvironrnent? Am. J. Physiol. Lung Cell Mol. Physiol. 279:562.
20. Madtes D.K., A.L. Elston, L.A. Kaback and J.G. Clark. 2001. Selective induction of tissue inhibitor of metalloproteinase-1 in bleomycin-induced pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 24:599.
21. Adamson I.Y. and D.H. Bowden. 1974. The pathogenesis of bloemycin-induced pulmonary fibrosis in mice. Am. J. Pathol. 77:185.
22. Krous H.F. and W.B. Hamlin. 1973. Pulmonary toxicity due to bleomycin. Report of a case. Arch. Pathol. 95:407.
23. Lindenschmidt R.C., A.F. Tryka, G.A. Godfrey, E.L. Frome and H. Witschi. 1986. Intratracheal versus intravenous administration of bleomycin in mice: acute effects. Toxicol. Appl. Pharmacol. 85:69.
24. Schrier D.J., R.G. Kunkel and S.H. Phan. 1983. The role of strain variation in murine bleomycin-induced pulmonary fibrosis. Am. Rev. Respir. Dis. 127:63.
25. Cavarra E., F. Carraro, S. Fineschi, A. Naldini, B. Bartalesi, A. Pucci and G. Lungarella. 2004. Early response to bleomycin is characterized by different cytokine and cytokine receptor profiles in lungs. Am. J. Physiol. Lung Cell Mol. Physiol. 287:1186.
26. Kolb M., P. Bonniaud, T. Galt, P.J. Sime, M.M. Kelly, P.J. Margetts and J. Gauldie. 2002. Differences in the fibrogenic response after transfer of active transforming growth factor-beta1 gene to lungs of "fibrosis- prone" and "fibrosis-resistant" mouse strains. Am. J. Respir. Cell Mol. Biol. 27:141.
27. Gauldie J. 2002. Pro: Inflammatory mechanisms are a minor component of the pathogenesis of idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 165:1205.
28. Morris D.G., X. Huang, N. Kaminski, Y. Wang, S.D. Shapiro, G. Dolganov, A. Glick and D. Sheppard. 2003. Loss of integrin alpha(v)beta6-mediated TGF-beta activation causes Mmp12-dependent emphysema. Nature 422:169.
29. Beeh K.M., J. Beier, O. Kornmann and R. Buhl. 2003. Sputum matrix metalloproteinase-9, tissue inhibitor of metalloprotinease-1, and their molar ratio in patients with chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis and healthy subjects. Respir. Med. 97:634.
30. Strieter R.M. 2002. Con: Inflammatory mechanisms are not a minor component of the pathogenesis of idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 165:1206.
31. Clark J.G. and C. Kuhn. 1982. Bleomycin-induced pulmonary fibrosis in hamsters: effect of neutrophil depletion on lung collagen synthesis. Am. Rev. Respir. Dis. 126:737.
32. Hamaguchi Y., Y. Nishizawa, M. Yasui, et al. 2002. Intercellular adhesion molecule-1 and L-selectin regulate bleomycin-induced lung fibrosis. Am. J. Pathol. 161:1607.
33. Keane M.P., J.A. Belperio, T.A. Moore, B.B. Moore, D.A. Arenberg, R.E. Smith, M.D. Burdick, S.L. Kunkel and R.M. Strieter. 1999. Neutralization of the CXC chemokine, macrophage inflammatory protein-2, attenuates bleomycin-induced pulmonary fibrosis. J. Immunol. 162:5511.
34. Tokuda A., M. Itakura, N. Onai, H. Kimura, T. Kuriyama and K. Matsushima. 2000. Pivotal role of CCR1-positive leukocytes in bleomycin-induced lung fibrosis in mice. J. Immunol. 164:2745.
35. Obayashi Y., I. Yamadori, J. Fujita, T. Yoshinouchi, N. Ueda and J. Takahara. 1997. The role of neutrophils in the pathogenesis of idiopathic pulmonary fibrosis. Chest 112:1338.
36. White E.S., M.H. Lazar and V.J. Thannickal. 2003. Pathogenetic mechanisms in usual interstitial pneumonia/idiopathic pulmonary fibrosis. J. Pathol. 201:343.
37. Coker R.K., G.J. Laurent, S. Shahzeidi, P.A. Lympany, R.M. Du Bois, P.K. Jeffery and R.J. Mcanulty. 1997. Transforming growth factors-beta 1, -beta 2, and -beta 3 stimulate fibroblast procollagen production in vitro but are differentially expressed during bleomycin-induced lung fibrosis. Am. J. Pathol. 150:981.
38. Botelho F.M., D.R. Edwards and C.D. Richards. 1998. Oncostatin M stimulates c-Fos to bind a transcriptionally responsive AP-1 element within the tissue inhibitor of metalloproteinase-1 promoter. J. Biol. Chem. 273:5211.
39. Addis-Lieder E., J. Köhl and G. Chiaramonte. 2005. Opposing regulatory roles of complement factor 5 in the development of bleomycin-induced pulmonary fibrosis. J. Immunol. 175:1894.
40. Ruiz V., R.M. Ordonez, J. Berumen, R. Ramirez, B. Uhal, C. Becerril, A. Pardo and M. Selman. 2003. Unbalanced collagenases/TIMP-1 expression and epithelial apoptosis in experimental lung fibrosis. Am. J. Physiol. Lung Cell Mol. Physiol. 285:1026.
41. Delclaux C., C. Delacourt, M.P. D'Ortho, V. Boyer, C. Lafuma and A. Harf. 1996. Role of gelatinase B and elastase in human polymorphonuclear neutrophil migration across basement membrane. Am. J. Respir. Cell Mol. Biol. 14:288.
42. Atkinson J.J. and R.M. Senior. 2003. Matrix metalloproteinase-9 in lung remodeling. Am. J. Respir. Cell Mol. Biol. 28:12.
43. Pelus L.M., H. Bian, A.G. King and S. Fukuda. 2004. Neutrophil-derived MMP-9 mediates synergistic mobilization of hematopoietic stem and progenitor cells by the combination of G-CSF and the chemokines GRObeta/CXCL2 and GRObetaT/CXCL2delta4. Blood 103:110.
44. Betsuyaku T., Y. Fukuda, W.C. Parks, J.M. Shipley and R.M. Senior. 2000. Gelatinase B is required for alveolar bronchiolization after intratracheal bleomycin. Am. J. Pathol. 157:525.
45. Kunugi S., Y. Fukuda, M. Ishizaki and N. Yamanaka. 2001. Role of MMP-2 in alveolar epithelial cell repair after bleomycin administration in rabbits. Lab. Invest. 81:1309.
46. Winkler M.K. and J.L. Fowlkes. 2002. Metalloproteinase and growth factor interactions: do they play a role in pulmonary fibrosis? Am. J. Physiol. Lung Cell Mol. Physiol. 283:1.
47. Kim K.H., K. Burkhart, P. Chen, C. Frevert, J. Randolph-Habecker, R.C. Hackman, P.D. Soloway and D.K. Madtes. 2005. Tissue Inhibitor of MP-1 Deficiency Amplifies Acute Lung Injury in Bleomycin Exposed Mice. Am. J. Respir. Cell Mol. Biol. 33:271.
48. Kim H., T. Oda, J. Lopez-Guisa, D. Wing, D.R. Edwards, P.D. Soloway and A.A. Eddy. 2001. TIMP-1 deficiency does not attenuate interstitial fibrosis in obstructive nephropathy. J. Am. Soc. Nephrol. 12:736.
49. Leco K.J., P. Waterhouse, O.H. Sanchez, K.L. Gowing, A.R. Poole, A. Wakeham, T.W. Mak and R. Khokha. 2001. Spontaneous air space enlargement in the lungs of mice lacking tissue inhibitor of metalloproteinases-3 (TIMP-3). J. Clin. Invest. 108:817.
50. Robertson J., G.E. Martin, K. Ask, S. Gilpin, J. Gauldie and M. Kolb. 2005. Balb/c Mice Develop Bleomycin Induced Pulmonary Fibrosis in the Presence of Abundant TIMP-1. In: Proceedings of the American Thoracic Society, annual International Conference, San Diego, USA. [A28] Poster: 809.